Nuon Therapeutics 
Welcome,         Profile    Billing    Logout  
 1 Product   24 Diseases  1 Product   10 Trials   344 News 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rizaben (tranilast) / Kissei, Nuon Therapeutics
ChiCTR2000030002: Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19)

Recruiting
4
60
China
conventional therapy ;conventional therapy and Tranilast
The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital); The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital), Anhui Development and Reform Commission
Novel Coronavirus Pneumonia (COVID-19)
 
 
NCT05130892: Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI

Completed
4
132
RoW
Colchicine, Tranilast, Oridonin
Wuhan Union Hospital, China
NLRP3, hsCRP, Percutaneous Coronary Intervention
02/23
02/23
NCT06307288: Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea

Enrolling by invitation
4
45
RoW
minocycline, tranilast
Second Affiliated Hospital of Xi'an Jiaotong University
Rosacea
06/24
06/24
NCT03923140: A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)

Recruiting
2
71
RoW
Tranilast, Rizaben
Peking Union Medical College Hospital
Cryopyrin-Associated Periodic Syndromes
04/24
10/24
NCT05626829: Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

Recruiting
2
18
RoW
Tranilast
Jian Guan
Nasopharyngeal Carcinoma, Recurrent Cancer
07/24
11/24
TAPES, NCT06643689: Tranilast Vs. Steroids to Prevent Esophageal Stricture () After Endoscopic Resection for Superficial Neoplasms

Not yet recruiting
2
394
RoW
Tranilast, Dexamethasone
Second Affiliated Hospital, School of Medicine, Zhejiang University, The Third People's Hospital of Hangzhou, Xiangya Hospital of Central South University
Esophageal Stricture, Esophageal Neoplasms
12/27
12/28
ChiCTR1800015808: Pilot Clinical Study of Chemo-Cocktail (TTF) for Recurrent Glioblastoma

Recruiting
1
10
 
temmozoldmide+tranilast+fasudil
Huashan Hospital, Fudan University; Huashan Hospital, Fudan University, No
Recurrent Glioblastoma
 
 
NCT03490708: A Clinical Study of Tranilast in the Treatment of Mucinoses

Not yet recruiting
1
56
NA
Tranilast
The First Affiliated Hospital with Nanjing Medical University
Mucinoses
06/22
12/22
NCT06689514: Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia

Not yet recruiting
1
30
RoW
alpha receptor antagonist, Low dose Tranilast, High dose Tranilast
Yifeng Jing
Prostatic Hypertrophy, Benign
12/25
12/25
ChiCTR1900028455: A single center, randomized, single blind, controlled trial for tranilast in the treatment of gout

Not yet recruiting
N/A
160
 
take one tranilast capsule (each containing 0.1g of tranilast), three times a day, take it after three meals, treatment for one week ;take 2 capsules of tranilast (0.1g of tranilast per capsule), 3 times / day, after three meals, treatment for 1 week ;Take 1 diclofenac capsule (each containing 50mg of diclofenac) twice a day, take it after breakfast and dinner, and treat for 1 week ;Take 1 colchicine tablet (each tablet contains 0.5mg colchicine), 3 times / day, take after three meals, treatment for 1 week
The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital); The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital), Researchers spontaneous
Gout
 
 
acetylcysteine/pentoxifylline (PTL 202) / IntelGenx, Nuon Therapeutics
No trials found
PTL 303 / Nuon Therapeutics
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rizaben (tranilast) / Kissei, Nuon Therapeutics
ChiCTR2000030002: Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19)

Recruiting
4
60
China
conventional therapy ;conventional therapy and Tranilast
The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital); The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital), Anhui Development and Reform Commission
Novel Coronavirus Pneumonia (COVID-19)
 
 
NCT05130892: Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI

Completed
4
132
RoW
Colchicine, Tranilast, Oridonin
Wuhan Union Hospital, China
NLRP3, hsCRP, Percutaneous Coronary Intervention
02/23
02/23
NCT06307288: Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea

Enrolling by invitation
4
45
RoW
minocycline, tranilast
Second Affiliated Hospital of Xi'an Jiaotong University
Rosacea
06/24
06/24
NCT03923140: A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)

Recruiting
2
71
RoW
Tranilast, Rizaben
Peking Union Medical College Hospital
Cryopyrin-Associated Periodic Syndromes
04/24
10/24
NCT05626829: Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

Recruiting
2
18
RoW
Tranilast
Jian Guan
Nasopharyngeal Carcinoma, Recurrent Cancer
07/24
11/24
TAPES, NCT06643689: Tranilast Vs. Steroids to Prevent Esophageal Stricture () After Endoscopic Resection for Superficial Neoplasms

Not yet recruiting
2
394
RoW
Tranilast, Dexamethasone
Second Affiliated Hospital, School of Medicine, Zhejiang University, The Third People's Hospital of Hangzhou, Xiangya Hospital of Central South University
Esophageal Stricture, Esophageal Neoplasms
12/27
12/28
ChiCTR1800015808: Pilot Clinical Study of Chemo-Cocktail (TTF) for Recurrent Glioblastoma

Recruiting
1
10
 
temmozoldmide+tranilast+fasudil
Huashan Hospital, Fudan University; Huashan Hospital, Fudan University, No
Recurrent Glioblastoma
 
 
NCT03490708: A Clinical Study of Tranilast in the Treatment of Mucinoses

Not yet recruiting
1
56
NA
Tranilast
The First Affiliated Hospital with Nanjing Medical University
Mucinoses
06/22
12/22
NCT06689514: Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia

Not yet recruiting
1
30
RoW
alpha receptor antagonist, Low dose Tranilast, High dose Tranilast
Yifeng Jing
Prostatic Hypertrophy, Benign
12/25
12/25
ChiCTR1900028455: A single center, randomized, single blind, controlled trial for tranilast in the treatment of gout

Not yet recruiting
N/A
160
 
take one tranilast capsule (each containing 0.1g of tranilast), three times a day, take it after three meals, treatment for one week ;take 2 capsules of tranilast (0.1g of tranilast per capsule), 3 times / day, after three meals, treatment for 1 week ;Take 1 diclofenac capsule (each containing 50mg of diclofenac) twice a day, take it after breakfast and dinner, and treat for 1 week ;Take 1 colchicine tablet (each tablet contains 0.5mg colchicine), 3 times / day, take after three meals, treatment for 1 week
The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital); The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital), Researchers spontaneous
Gout
 
 
acetylcysteine/pentoxifylline (PTL 202) / IntelGenx, Nuon Therapeutics
No trials found
PTL 303 / Nuon Therapeutics
No trials found

Download Options